These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 22213637)

  • 21. Discovery of oral fluid biomarkers for human oral cancer by mass spectrometry.
    Hu S; Yu T; Xie Y; Yang Y; Li Y; Zhou X; Tsung S; Loo RR; Loo JR; Wong DT
    Cancer Genomics Proteomics; 2007; 4(2):55-64. PubMed ID: 17804867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systematic identification of substrates for profiling of secreted proteases from Aspergillus species.
    Schaal R; Kupfahl C; Buchheidt D; Neumaier M; Findeisen P
    J Microbiol Methods; 2007 Nov; 71(2):93-100. PubMed ID: 17707935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Membrane protease degradomics: proteomic identification and quantification of cell surface protease substrates.
    Butler GS; Dean RA; Smith D; Overall CM
    Methods Mol Biol; 2009; 528():159-76. PubMed ID: 19153692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum peptide/protein profiling by mass spectrometry provides diagnostic information independently of CA125 in women with an ovarian tumor.
    Callesen AK; Madsen JS; Iachina M; Vach W; Kruse TA; Jensen ON; Mogensen O
    Cancer Biomark; 2010; 6(2):73-82. PubMed ID: 20571233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic value of serum peptidome analyses for protease activated pathological conditions beyond cancer diagnosis.
    Hashiguchi T; Tanaka K; Lee LJ; Sasaki K; Natsugoe S; Kawahara K; Arimura K; Maruyama I
    Med Hypotheses; 2009 Nov; 73(5):760-3. PubMed ID: 19477605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A data-analytic strategy for protein biomarker discovery: profiling of high-dimensional proteomic data for cancer detection.
    Yasui Y; Pepe M; Thompson ML; Adam BL; Wright GL; Qu Y; Potter JD; Winget M; Thornquist M; Feng Z
    Biostatistics; 2003 Jul; 4(3):449-63. PubMed ID: 12925511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative profiling of serum glycoproteome by sequential purification of glycoproteins and 2-nitrobenzensulfenyl (NBS) stable isotope labeling: a new approach for the novel biomarker discovery for cancer.
    Ueda K; Katagiri T; Shimada T; Irie S; Sato TA; Nakamura Y; Daigo Y
    J Proteome Res; 2007 Sep; 6(9):3475-83. PubMed ID: 17705522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proteomic identification of serum biomarkers for head and neck cancer surveillance.
    Gourin CG; Zhi W; Adam BL
    Laryngoscope; 2009 Jul; 119(7):1291-302. PubMed ID: 19444892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MSQ: a tool for quantification of proteomics data generated by a liquid chromatography/matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometry based targeted quantitative proteomics platform.
    Oh JH; Pan S; Zhang J; Gao J
    Rapid Commun Mass Spectrom; 2010 Feb; 24(4):403-8. PubMed ID: 20069694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of non-covalent protein interactions by 'intensity fading' MALDI-TOF mass spectrometry: applications to proteases and protease inhibitors.
    Yanes O; Villanueva J; Querol E; Aviles FX
    Nat Protoc; 2007; 2(1):119-30. PubMed ID: 17401346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Proteomic profiling: the potential of Seldi-Tof for the identification of new cancer biomarkers].
    Solassol J; Marin P; Maudelonde T; Mangé A
    Bull Cancer; 2005 Sep; 92(9):763-8. PubMed ID: 16203265
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reproducibility of serum protein profiling by systematic assessment using solid-phase extraction and matrix-assisted laser desorption/ionization mass spectrometry.
    Callesen AK; Christensen Rd; Madsen JS; Vach W; Zapico E; Cold S; Jørgensen PE; Mogensen O; Kruse TA; Jensen ON
    Rapid Commun Mass Spectrom; 2008; 22(3):291-300. PubMed ID: 18181248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mass spectrometry-assisted protease substrate screening.
    Schlüter H; Rykl J; Thiemann J; Kurzawski S; Gobom J; Tepel M; Zidek W; Linscheid M
    Anal Chem; 2007 Feb; 79(3):1251-5. PubMed ID: 17263361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Strategies for plasma proteomic profiling of cancers.
    Omenn GS
    Proteomics; 2006 Oct; 6(20):5662-73. PubMed ID: 16991194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteomics in the diagnosis of hepatocellular carcinoma: focus on high risk hepatitis B and C patients.
    El-Aneed A; Banoub J
    Anticancer Res; 2006; 26(5A):3293-300. PubMed ID: 17094443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical proteomics: searching for better tumour markers with SELDI-TOF mass spectrometry.
    Engwegen JY; Gast MC; Schellens JH; Beijnen JH
    Trends Pharmacol Sci; 2006 May; 27(5):251-9. PubMed ID: 16600386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. "Reverse degradomics", monitoring of proteolytic trimming by multi-CE and confocal detection of fluorescent substrates and reaction products.
    Piccard H; Hu J; Fiten P; Proost P; Martens E; Van den Steen PE; Van Damme J; Opdenakker G
    Electrophoresis; 2009 Jul; 30(13):2366-77. PubMed ID: 19621364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protease specificity profiling by tandem mass spectrometry using proteome-derived peptide libraries.
    Schilling O; auf dem Keller U; Overall CM
    Methods Mol Biol; 2011; 753():257-72. PubMed ID: 21604128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic protein discovery using proteolytic peptide targeting and identification.
    Koomen JM; Zhao H; Li D; Abbruzzese J; Baggerly K; Kobayashi R
    Rapid Commun Mass Spectrom; 2004; 18(21):2537-48. PubMed ID: 15468157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteomic patterns: their potential for disease diagnosis.
    Xiao Z; Prieto D; Conrads TP; Veenstra TD; Issaq HJ
    Mol Cell Endocrinol; 2005 Jan; 230(1-2):95-106. PubMed ID: 15664456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.